We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Harmonization Could Hurt Drug Market, Consultant Says
Harmonization Could Hurt Drug Market, Consultant Says
June 16, 2006
The FDA’s move to harmonize its approach to risk management with its European counterparts could potentially lead some products to be withdrawn from the market because of rising costs, an industry consultant said.